Benzinga.com

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs

The U.S. Food and Drug Administration’s recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question. Check out the current price ...
Barron's

Data on Eli Lilly’s Weight Loss Pill Haven’t Thrilled Investors. New Updates Are Complicating the Picture.

The drugmaker Eli Lilly’s reign as the undisputed king of the weight loss trade came under threat in early August, after disappointing preliminary data on its closely watched experimental weight loss ...
AOL

This Fat-Burning Workout Will Help You Lose Weight--No Cardio Required

Some people prefer to jump on a treadmill when they show up at the gym. Cardio has many benefits for your heart, but if that's all you're doing, you're missing out on some key components for an ...
The Ledger

Padding its resume: Bok Tower Gardens gains worldwide attention for buoyant water lily

The international competition, started by Denver Botanic Gardens, included over 40 participants from nine countries. The giant Victoria water lilies are grown annually from seeds the size of a ...
Reuters

Lilly gets a boost from new weight-loss pill data as it weighs speedier approval in US

VIENNA, Sept 17 (Reuters) - Eli Lilly's (LLY.N), opens new tab bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and the company reaffirmed ...
The Gazette

Eli Lilly cautious on using FDA fast-track voucher for weight loss pill

FILE PHOTO: Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. REUTERS/Mike Blake/File Photo (Reuters) -Eli Lilly’s international president Patrik Jonsson said on ...
citizen

Lilly weight-loss pill could be FDA-approved by year-end

Eli Lilly experimental weight-loss pill could be fast-tracked under a one- to two-month review process recently launched by the U.S. Food and Drug Administration, several Wall Street analysts said.
The Gazette

Lilly gets a boost from new weight-loss pill data as it weighs speedier approval in US

VIENNA (Reuters) - Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, and the company reaffirmed that it was too soon to assume ...
Wall Street Journal

Eli Lilly’s Diabetes Drug Tops Novo Nordisk’s Oral Pill in Trial

Eli Lilly LLY-0.69%decrease; red down pointing triangle said new data from its Phase 3 trial of its investigational diabetes pill showed positive results in improving blood sugar levels, outperforming ...
Wall Street Journal

Eli Lilly’s New Diabetes Drug Shows Better Blood Sugar, Weight Loss Results Than Rival

Eli Lilly LLY0.75%increase; green up pointing triangle said new data from its Phase 3 trial of its investigational diabetes pill showed positive results in improving blood sugar levels, outperforming ...
Seeking Alpha

Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine

i Controlled for family-wise type 1 error rate. ii Percentage of participants achieving body weight reductions of ≥20% with orforglipron 6 mg was not controlled for ...